C-1 functionalization of the marinoquinoline scaffold generates novel and selective inhibitors of Toxoplasma gondii and Trypanosoma cruzi.
Toxoplasmosis and Chagas disease are parasitic diseases for which current treatments are limited by toxicity and suboptimal efficacy. Marinoquinolines have recently emerged as promising antiparasitic scaffolds, although structural modifications at position 1 of the marinoquinoline core remain unexplored. Herein, we rep...